San Diego + 1.858.314.1129

Sachin Bhatmuley represents clients in technology licensing and other complex technology-related transactions. Sachin helps clients achieve their business objectives by structuring and negotiating transactions in a broad range of technologies.

Sachin has extensive experience working with licensees and early-state device makers in the 4G/5G wireless communications space. He also has experience litigating complex patent disputes before district courts and the Patent Trial and Appeal Board (PTAB). Sachin has represented clients in software, semiconductors, mobile payments, wireless communications, and 3D-bioprinting litigations.

Prior to his law practice, Sachin was a technology licensing executive at a large technology company, where he established the company's sub-Sahara Africa presence. He also architected, established, and ran the company's Design in India Challenge and its in-house technology incubator. The success of this program led to the program being replicated in the company's other regional offices across Asia. Sachin has worked in multiple countries and has traveled extensively within Africa, Southeast Asia, and Europe.

Sachin also maintains an active pro bono practice representing clients in domestic violence restraining orders (DVROs), guardianship, and immigration matters.

Sachin coaches trial techniques and legal principles to high school students as an attorney coach for the San Diego High School Mock Trial Competition.


  • J.F. Lehman & Company portfolio company acquires White Lake Dock & DredgeJones Day advised J.F. Lehman & Company in the acquisition and financing by portfolio company, ENTACT, LLC, of White Lake Dock & Dredge, Inc.
  • Cibus combines with CalyxtJones Day advised Cibus Global, LLC (“Cibus”), a San Diego based leader in precision gene editing in agriculture, in connection with an all-stock merger with Calyxt, Inc. (NASDAQ: CLXT), under which Cibus and Calyxt created an industry-leading company that combines two pioneers in agriculture-based gene editing and establishes one of the world’s most sophisticated facilities for trait development and plant breeding.
  • Junshi grants exclusive rights to Dr. Reddy's for toripalimab cancer treatmentJones Day represented Shanghai Junshi Biosciences Co., Ltd. ("Junshi") in its grant of exclusive rights related to the development and commercialization of toripalimab, an anti-PD1 monoclonal antibody, to Dr. Reddy's Laboratories for the territory of Latin America, India, South Africa, and an option to expand the territory to include Australia and New Zealand and potential other countries.
  • Additional Publications

    • January 14, 2021
      Structuring the Deal to Avoid Patent Exhaustion (Post Impression Products v. Lexmark), Transactions: The Tennessee Journal of Business Law, Fall 2020
    • May 7, 2020
      Defend Trade Secrets Act and The Seizure Provision: Useful or Superfluous?, Review of Intellectual Property Law - University of Illinois
    • March 1, 1997
      Performance of MHPM in Rician and Rayleigh fading mobile channels, IEEE Transactions on Communications, Volume: 45 Issue: 3